PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LUNA vs. KRMD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between LUNA and KRMD is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

LUNA vs. KRMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Luna Innovations Incorporated (LUNA) and Repro Med Systems, Inc. (KRMD). The values are adjusted to include any dividend payments, if applicable.

-50.00%0.00%50.00%100.00%SeptemberOctoberNovemberDecember2025February
-61.15%
87.78%
LUNA
KRMD

Key characteristics

Sharpe Ratio

LUNA:

-0.73

KRMD:

1.33

Sortino Ratio

LUNA:

-1.33

KRMD:

2.13

Omega Ratio

LUNA:

0.80

KRMD:

1.25

Calmar Ratio

LUNA:

-0.92

KRMD:

0.99

Martin Ratio

LUNA:

-1.28

KRMD:

6.84

Ulcer Index

LUNA:

67.88%

KRMD:

12.12%

Daily Std Dev

LUNA:

118.92%

KRMD:

62.59%

Max Drawdown

LUNA:

-96.90%

KRMD:

-97.69%

Current Drawdown

LUNA:

-92.65%

KRMD:

-66.59%

Fundamentals

Market Cap

LUNA:

$27.06M

KRMD:

$190.22M

EPS

LUNA:

-$0.03

KRMD:

-$0.26

Returns By Period

In the year-to-date period, LUNA achieves a -56.48% return, which is significantly lower than KRMD's 7.79% return. Over the past 10 years, LUNA has underperformed KRMD with an annualized return of -3.99%, while KRMD has yielded a comparatively higher 26.83% annualized return.


LUNA

YTD

-56.48%

1M

-12.15%

6M

-61.79%

1Y

-87.33%

5Y*

-36.57%

10Y*

-3.99%

KRMD

YTD

7.79%

1M

1.47%

6M

83.63%

1Y

93.02%

5Y*

-10.65%

10Y*

26.83%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

LUNA vs. KRMD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LUNA
The Risk-Adjusted Performance Rank of LUNA is 77
Overall Rank
The Sharpe Ratio Rank of LUNA is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of LUNA is 66
Sortino Ratio Rank
The Omega Ratio Rank of LUNA is 55
Omega Ratio Rank
The Calmar Ratio Rank of LUNA is 22
Calmar Ratio Rank
The Martin Ratio Rank of LUNA is 1111
Martin Ratio Rank

KRMD
The Risk-Adjusted Performance Rank of KRMD is 8080
Overall Rank
The Sharpe Ratio Rank of KRMD is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of KRMD is 8181
Sortino Ratio Rank
The Omega Ratio Rank of KRMD is 7676
Omega Ratio Rank
The Calmar Ratio Rank of KRMD is 7878
Calmar Ratio Rank
The Martin Ratio Rank of KRMD is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LUNA vs. KRMD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Luna Innovations Incorporated (LUNA) and Repro Med Systems, Inc. (KRMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for LUNA, currently valued at -0.73, compared to the broader market-2.000.002.004.00-0.731.33
The chart of Sortino ratio for LUNA, currently valued at -1.33, compared to the broader market-6.00-4.00-2.000.002.004.006.00-1.332.13
The chart of Omega ratio for LUNA, currently valued at 0.80, compared to the broader market0.501.001.502.000.801.25
The chart of Calmar ratio for LUNA, currently valued at -0.92, compared to the broader market0.002.004.006.00-0.920.99
The chart of Martin ratio for LUNA, currently valued at -1.28, compared to the broader market0.0010.0020.0030.00-1.286.84
LUNA
KRMD

The current LUNA Sharpe Ratio is -0.73, which is lower than the KRMD Sharpe Ratio of 1.33. The chart below compares the historical Sharpe Ratios of LUNA and KRMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50SeptemberOctoberNovemberDecember2025February
-0.73
1.33
LUNA
KRMD

Dividends

LUNA vs. KRMD - Dividend Comparison

Neither LUNA nor KRMD has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

LUNA vs. KRMD - Drawdown Comparison

The maximum LUNA drawdown since its inception was -96.90%, roughly equal to the maximum KRMD drawdown of -97.69%. Use the drawdown chart below to compare losses from any high point for LUNA and KRMD. For additional features, visit the drawdowns tool.


-95.00%-90.00%-85.00%-80.00%-75.00%-70.00%-65.00%-60.00%SeptemberOctoberNovemberDecember2025February
-92.65%
-66.59%
LUNA
KRMD

Volatility

LUNA vs. KRMD - Volatility Comparison

Luna Innovations Incorporated (LUNA) has a higher volatility of 29.96% compared to Repro Med Systems, Inc. (KRMD) at 18.30%. This indicates that LUNA's price experiences larger fluctuations and is considered to be riskier than KRMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%SeptemberOctoberNovemberDecember2025February
29.96%
18.30%
LUNA
KRMD

Financials

LUNA vs. KRMD - Financials Comparison

This section allows you to compare key financial metrics between Luna Innovations Incorporated and Repro Med Systems, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab